Roche Head to Speak at 6th Drug Design & Medicinal Chem. Conf. (June 7-8, 2012, San Diego)
Francesca Milleti, Head of Cheminformatics & Statistics at Hoffmann-La Roche to give a Featured Presentation on "SAR analysis 3.0" at the 6th Drug Design & Medicinal Chemistry Conference on June 7-8, 2012 in San Diego, CA
- (1888PressRelease) March 26, 2012 - Francesca Milleti, Head of Cheminformatics & Statistics at Hoffmann-La Roche to give a Featured Presentation on "SAR analysis 3.0" at the 6th Drug Design & Medicinal Chemistry Conference on June 7-8, 2012 in San Diego, CA.
GTC is proud to present the 6th Drug Design and Medicinal Chemistry Conference held on June 7-8, 2012 at the Hilton San Diego Resort & Spa in San Diego, CA, which will bring together leading industrial and academic experts to further collaborate on the exciting advances in the field. Experts will facilitate discourse on topics such as strategies for hit and target identification, fragment based drug design, chemoinformatics, protein-protein interactions, ligand based drug design, computer aided drug design, protein flexibility, high performance computing, covalent inhibitors, mutational resistance, selectivity of kinase inhibitors, potency, specificity, lead optimization, ADMET, safety in drug discovery, advances in drug delivery and much more.
The top companies and experts in the field of Drug Design & Medicinal Chemistry will come together to discuss the latest discoveries. Companies include ArQule, Array BioPharma, Astex Therapeutics, OSI Pharmaceuticals, GlaxoSmithKline, Merck, Pfizer, Bayer, Genentech, Hoffmann-La Roche, Eli Lilly, Genzyme.
Keynote & Featured Speakers Include:
Barry A. Morgan, Vice President, Molecular Discovery Research, Site Head in Boston, GlaxoSmithKline
Alexander Hillisch, Director, Medicinal Chemistry, Head, Computational Chemistry, Bayer
Francesca Milleti, Head, Cheminformatics & Statistics, Hoffmann-La Roche
For more information, please visit www.gtcbio.com